Xellar Biosystems

Xellar Biosystems is combining machine learning and AI to advance drug development. Their organ-on-a-chip technology can help accelerate drug discovery and development by reducing the gap between preclinical studies and successful clinical trials. Xellar has engineered a micro-organ matrix that can help replicate the human system, providing better, more reliable drug efficacy and safety data. Their human disease modeling systems, using 3D culture can help predict drug toxicity. Their recapitulation of an organ’s microenvironment even includes vascular flow and can integrate immune cells for a highly human compatible in vitro system.Combining their 3D cell imaging techniques and organ-on-a-chip technology, Xellar is advancing biomedical research and therapeutic development for high unmet medical needs.

Jobs: